Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir process-comparison study in type 1 diabetes
2006-004733-15Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of insulin detemir and insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change from baseline to week 52 in insulin cross-reacting antibodies. Started Mar 2007; status: completed.
02
Drugs
insulin detemirinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-004733-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004733-15.